Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 1,000 shares at $14.80 ($15K) on 2007-01-03, disclosed to the SEC on 2007-01-04.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 200 | $3K | 19.7% |
| 2 | $14.66 | 100 | $1K | 9.9% |
| 3 | $14.71 | 100 | $1K | 9.9% |
| 4 | $14.80 | 100 | $1K | 9.9% |
| 5 | $14.95 | 100 | $1K | 10.0% |
| 6 | $15.00 | 200 |
| $3K |
| 20.2% |
| 7 | $15.06 | 100 | $2K | 10.1% |
| 8 | $15.38 | 100 | $2K | 10.3% |
| Total | $14.88 avg | 1,000 | $15K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |